HLA-C and neoplasm: At a second step of anticancer immunity, suitable tumor antigens are expressed but their presentation in combination with MHC on the tumor cell surface fails due to alterations in the antigen presenting mechanism such as in proteasome subunits, transporters associated with antigen processing, beta-2-microglobulin or MHC itself[47].